Will an mRNA vaccine receive regulatory approval for a new infectious-disease indication by 2028?
Market says 50% YES right now. Closes 31 Jan 2029.
Predict whether a national medicines regulator will approve an mRNA vaccine for a new infectious-disease indication by the end of 2028.
How this market resolves
YES requires a formal marketing approval for an mRNA vaccine and a newly approved infectious-disease indication before January 1, 2029; otherwise NO.
Category: Health